Advanced Technology Ventures focuses on investing in the ICT, infrastructure, consumer technology, bio-pharmaceuticals and medical industry.
Business Model:
Revenue: $15.5M
Employees: 11-50
Address: 485 Ramona St
City: Palo Alto
State: CA
Zip: 94301
Country: US
[Advanced Technology Ventures](http://www.atvcapital.com) (ATV) is a bi-coastal venture capital firm that focuses on communications, infrastructure, software and services, consumer technology, biopharmaceuticals, medical devices and cleantech.
Contact Phone:
+16503218601
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2009 | Nuventix | Series C | 0 |
4/2000 | Sound Vision | Series A | 0 |
9/2002 | iConverse | Series C | 6M |
8/1998 | Avolent | Series B | 10M |
4/2014 | Nuvaira | Series D | 42M |
1/2014 | PowerVision | Series D | 0 |
4/2013 | Solar Junction | Venture Round | 8.1M |
1/1999 | Tripwire | Series A | 2.4M |
4/2013 | Planful | Venture Round | 6.5M |
3/2012 | GluMetrics | Venture Round | 13.3M |
6/2003 | GI Dynamics | Series A | 4.1M |
6/2000 | WorldStreet | Venture Round | 0 |
3/2005 | NeoScale Systems | Series D | 12M |
3/2003 | Hypnion | Series B | 47.5M |
11/1999 | Grassroots | Series A | 3.4M |
7/2003 | Tripwire | Series D | 8.3M |
9/1999 | MicroVention | Series B | 7.5M |
8/2010 | NeuroVista | Venture Round | 16.5M |
1/2008 | Integrated Media Measurement (IMMI) | Series C | 25M |
1/2004 | deNovis | Series C | 22M |
10/2001 | deNovis | Series B | 43.8M |
3/2004 | Precision I/O, Inc. | Series A | 10M |
3/2002 | Tripwire | Series C | 0 |
10/1998 | Linx Communications | Series A | 5.1M |
2/2005 | Five Prime Therapeutics | Series C | 45M |
12/2006 | SUB ONE TECHNOLOGY | Series B | 7M |
8/2000 | CaseCentral | Series B | 0 |
7/2008 | Qumu | Post-IPO Equity | 0 |
3/2017 | Oasys Water | Series B | 4M |
2/2013 | Astria Therapeutics | Venture Round | 9M |
10/2013 | Calithera Biosciences | Series D | 35M |
12/2012 | Calithera Biosciences | Series C | 2M |
3/2004 | Peakstone | Series D | 5M |
5/2000 | Express Action | Series A | 14M |
1/2013 | Planful | Series D | 17M |
5/2009 | Planful | Series B | 8.7M |
11/2001 | Peakstone | Series C | 12M |
2/2008 | PolyRemedy | Series B | 25M |
6/2006 | Silicor Materials | Series A | 9M |
5/2014 | Evergage | Series A | 4M |
12/2010 | Astria Therapeutics | Series A | 14.5M |
6/2004 | Emphasys Medical | Series D | 27.5M |
3/2009 | Ardian | Series C | 47M |
9/2008 | Valeritas | Series A | 50M |
12/2000 | Innovance | Series A | 75M |
8/2006 | Sanovi Technologies | Series B | 6.1M |
7/2001 | UpShot Corporation | Series E | 17M |
9/2012 | Nuvaira | Series B | 10.6M |
2/2013 | Gynesonics | Series D | 21M |
7/2015 | Gynesonics | Venture Round | 43M |
1/2007 | Gynesonics | Series B | 16.5M |
3/2002 | Polaris Networks | Series B | 52M |
3/2008 | Aperio Technologies | Series C | 20M |
5/2007 | Aperio Technologies | Series C | 10.6M |
11/2014 | Planful | Series E | 25M |
1/2016 | Cedexis | Series B | 0 |
12/2000 | Alfalight | Series B | 28M |
5/2008 | Solar Junction | Series A | 18M |
1/2003 | Visage Mobile | Series A | 5M |
12/2000 | Circe Biomedical | Private Equity Round | 28M |
9/2003 | Noosh | Series A | 5.1M |
8/2007 | Helixis | Series A | 10M |
4/2016 | Second Genome | Series B | 51M |
5/2012 | Evergage | Seed Round | 2M |
11/1999 | NewMediary | Series B | 5M |
3/2003 | OneChannel | Series D | 8.5M |
3/2000 | UpShot Corporation | Venture Round | 26M |
10/2007 | Zeltiq Aesthetics | Series B | 20.3M |
5/2000 | UBUBU, Inc. | Series B | 7M |
10/2000 | Optobionics Corporation | Venture Round | 4M |
2/2009 | Oasys Water | Series A | 10M |
6/2004 | Acme Packet | Series C | 1.4M |
11/1999 | Noosh | Private Equity Round | 0 |
7/2011 | PowerVision | Series C | 24M |
6/2000 | SpectraSwitch | Series B | 18.1M |
5/2007 | NeuroVista | Series B | 33.8M |
5/2004 | Plexxikon | Series B | 0 |
8/2018 | Actifio | Series F | 100M |
9/2010 | Actifio | Series B | 16M |
12/2011 | Actifio | Series C | 33.5M |
1/2000 | FactCity | Series A | 5.5M |
7/2006 | GluMetrics | Series B | 9M |
1/2004 | Intransa | Series C | 8M |
7/2000 | Linx Communications | Series B | 10.5M |
7/1998 | Avolent | Series A | 5M |
11/2005 | GreatPoint Energy | Series A | 7M |
3/2003 | Packet Design | Series A | 14.3M |
10/1999 | DirectAg.com | Venture Round | 12.6M |
2/2013 | Nuvaira | Series C | 10M |
3/2005 | XTENT | Series C | 25M |
7/2006 | Engage | Post-IPO Equity | 5M |
9/2007 | Apprion | Series B | 12M |
11/2003 | Percardia | Series D | 23.5M |
1/2014 | Aquion Energy | Series D | 20M |
3/2008 | Coskata | Series B | 19.5M |
4/2000 | Endurance International Group | Venture Round | 11.5M |
11/2012 | Modria | Seed Round | 1.3M |
6/2008 | [x+1] | Series A | 0 |
2/2002 | Wave7 Optics | Series B | 23M |
1/2003 | CaseCentral | Series D | 2.2M |
8/2013 | Coskata | Debt Financing | 3M |
5/2000 | Opthos | Series A | 14.9M |
9/2014 | Ivantis | Series B | 25M |
5/2003 | Redline Networks | Series C | 0 |
1/2003 | Intransa | Series B | 6M |
9/2010 | Qumu | Post-IPO Debt | 0 |
7/2000 | Peakstone | Series B | 15M |
7/2004 | Wave7 Optics | Venture Round | 6M |
8/2001 | CaseCentral | Series C | 5M |
5/2014 | EndoGastric Solutions | Series G | 0 |
6/2001 | CeLight | Series B | 32.5M |
9/2008 | Anagran | Series D | 0 |
1/2008 | Anagran | Series C | 12M |
3/2008 | Cenzic | Series D | 10M |
11/2013 | Astria Therapeutics | Series B | 32.4M |
6/2010 | Planful | Series C | 15M |
12/2007 | PowerVision | Series B | 20M |
2/2019 | Nuvaira | Equity | 79M |
2/2002 | Innovance | Series B | 0 |
6/2011 | Evergage | Angel Round | 250k |
7/2007 | NeoScale Systems | Series F | 8M |
8/2004 | Intransa | Series D | 24M |
7/2014 | Gynesonics | Debt Financing | 28.4M |
1/2018 | Gynesonics | Private Equity Round | 75M |
8/2003 | Compassoft | Series A | 4M |
9/2008 | Proteolix | Series C | 79M |
6/2003 | Vivato | Series C | 44.5M |
3/2012 | EndoGastric Solutions | Series G | 10.9M |
2/2002 | Intransa | Venture Round | 10M |
6/2010 | Zeltiq Aesthetics | Series D | 25M |
1/2005 | Visage Mobile | Series C | 22.8M |
8/2013 | Rive Technology | Series D | 0 |
11/2008 | CombineNet | Series E | 9.9M |
9/2002 | SpectraSwitch | Series C | 7.5M |
8/2012 | QuickPay | Seed Round | 3.5M |
6/2011 | PolyRemedy | Series C | 20M |
8/2001 | Onix Microsystems | Series C | 95M |
3/2008 | Handango | Series C | 0 |
4/2012 | EndPlay | Series C | 21.5M |
5/2004 | e-Security | Series C | 5M |
1/2001 | Black Pearl | Series C | 14.3M |
1/2011 | [x+1] | Series B | 0 |
1/2002 | SpectraSwitch | Series B | 6M |
6/2018 | EndoGastric Solutions | Series I | 0 |
11/2008 | Silicor Materials | Series B | 101.8M |
8/2000 | OneChannel | Series C | 0 |
9/2006 | Handango | Series B | 60.5M |
2/2000 | Grassroots | Series B | 0 |
10/1999 | Decide.com | Series B | 16.5M |
4/2005 | ChannelAdvisor | Series B | 18M |
11/2006 | Ardian | Series B | 10.1M |
7/2011 | Verastem Oncology | Series B | 32M |
4/2004 | Omneon | Venture Round | 0 |
9/2008 | ChannelAdvisor | Series D | 0 |
2/2012 | Solar Junction | Series D | 19.2M |
6/2013 | Second Genome | Series A | 0 |
9/2011 | Valeritas | Series C | 150M |
12/2015 | EndoGastric Solutions | Venture Round | 0 |
3/2002 | Bermai | Series A | 15M |
6/2010 | Altura Medical | Series A | 20M |
6/2003 | Bermai | Series B | 12M |
12/2001 | Bermai | Series A | 12M |
7/2005 | Cenzic | Series C | 15M |
6/2000 | Avolent | Series C | 30M |
7/2001 | Redline Networks | Series B | 10M |
12/2005 | Aperio Technologies | Venture Round | 12M |
10/2012 | Fuze, an 8x8 company | Series A | 16.5M |
12/2002 | Striva | Series B | 12.7M |
6/2000 | Onix Microsystems | Series B | 35.5M |
5/2007 | Compassoft | Series B | 7M |
6/2010 | Acceleron Pharma | Venture Round | 10.3M |
10/2001 | College Publisher, Inc. | Series B | 8.5M |
12/2002 | Alfalight | Series C | 15M |
10/2003 | Critical Therapeutics,Inc. | Series B | 56M |
12/2011 | Astria Therapeutics | Series A | 8M |
4/2010 | Astria Therapeutics | Series A | 39M |
6/2009 | Silicor Materials | Series C | 60M |
12/2010 | Rive Technology | Series C | 25M |
9/2003 | Wave7 Optics | Series C | 30.5M |
8/2007 | Rive Technology | Series A | 8.4M |
3/2014 | Actifio | Series E | 100M |
8/2000 | Annuncio Software | Venture Round | 36M |
7/1999 | Omneon | Series B | 0 |
12/1999 | OneChannel | Series B | 12M |
3/2000 | Annuncio Software | Venture Round | 0 |
6/2008 | Wakonda Technologies | Series A | 3.2M |
3/2008 | Hydra Biosciences | Series C | 34M |
1/2001 | CytoLogix | Series B | 0 |
2/2004 | CombineNet | Series C | 12M |
9/2000 | deNovis | Series A | 32M |
7/2010 | Calithera Biosciences | Series A | 40M |
3/2015 | Thrasos | Series D | 21M |
10/2012 | Thrasos | Series C | 35M |
8/2010 | EndoGastric Solutions | Series F | 0 |
6/2009 | EndoGastric Solutions | Venture Round | 3.8M |
11/2005 | Portola Pharmaceuticals | Series B | 46M |
6/2003 | EndoGastric Solutions | Series A | 5M |
9/2004 | EndoGastric Solutions | Series B | 12M |
8/2006 | Acceleron Pharma | Series B | 30M |
12/2005 | Hypnion | Series B | 0 |
7/2014 | Valeritas | Series D | 45M |
1/2009 | Hydra Biosciences | Series D | 22M |
3/2009 | GI Dynamics | Series C | 0 |
12/1997 | Endius | Series B | 0 |
5/2004 | GI Dynamics | Series B | 0 |
11/2011 | Calithera Biosciences | Venture Round | 4M |
12/2005 | Visage Mobile | Series D | 30M |
1/2004 | Hydra Biosciences | Series B | 0 |
11/2001 | Opthos | Series B | 21.6M |
11/2008 | Coskata | Series C | 40M |
7/2010 | Coskata | Series D | 23.7M |
8/2008 | GluMetrics | Series C | 20.1M |
5/2007 | ChannelAdvisor | Series C | 30M |
7/2002 | Hydra Biosciences | Series A | 9.3M |
3/2010 | Solar Junction | Series C | 13.3M |
11/2005 | Anagran | Series B | 14M |
10/2007 | Acceleron Pharma | Series C | 31M |
1/2003 | Ardais Corporation | Series C | 14M |
1/2006 | WildTangent | Venture Round | 13M |
4/2013 | Aquion Energy | Series D | 35M |
9/2011 | Aquion Energy | Venture Round | 30M |
10/2013 | Fuze, an 8x8 company | Series B | 10M |
6/2000 | WorldChain | Series A | 10.2M |
3/2005 | Nominum | Series D | 16M |
2/2000 | Tripwire | Series B | 9M |
8/2008 | AltaRock Energy | Series B | 26.3M |
9/2006 | Liquid Engines | Series C | 5.5M |
2/2004 | Liquid Engines | Series C | 9.2M |
6/2008 | Rive Technology | Series B | 14M |
1/2013 | GluMetrics | Debt Financing | 5.6M |
5/2003 | TranS1 | Series B | 0 |
9/1987 | Spectra Vision | Venture Round | 150k |
3/1988 | Spectra Vision | Venture Round | 100k |
2/2006 | CombineNet | Series D | 7.7M |
8/2011 | Cedexis | Series A | 11.2M |
1/2006 | Apprion | Series A | 7.5M |
1/2006 | Browster | Series A | 5.8M |
7/2005 | Ceterus Networks | Series D | 5.3M |
1/1997 | Endius | Series A | 3.5M |
3/2006 | Zeltiq Aesthetics | Series A | 7.5M |
11/1999 | UBUBU, Inc. | Venture Round | - |
5/2004 | WildTangent | Series D | 0 |
11/2009 | EndoGastric Solutions | Series E | 0 |
10/2009 | EndoGastric Solutions | Venture Round | 0 |
6/2012 | EndoGastric Solutions | Venture Round | 0 |
4/2012 | EndoGastric Solutions | Venture Round | 0 |
10/2000 | Ardais Corporation | Series A | 9M |
2/2019 | Nuvaira | Series E | 0 |
8/2018 | Actifio | Series F | 0 |
6/2018 | EndoGastric Solutions | Series I | 0 |
1/2018 | Gynesonics | Private Equity Round | 0 |
3/2017 | Oasys Water | Series B | 0 |
4/2016 | Second Genome | Series B | 0 |
1/2016 | Cedexis | Series B | 0 |
12/2015 | EndoGastric Solutions | Venture Round | 0 |
7/2015 | Gynesonics | Venture Round | 0 |
3/2015 | Thrasos | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|